Russian Federation
from 01.01.2019 until now
Russian Federation
from 01.01.2021 until now
Russian Federation
Over the past decade, there has been an increase in the number of cases of cervical cancer: approximately 530,000 new diagnoses are recorded worldwide every year. In the Russian Federation, 18,369 cases of the disease were recorded in 2022, with a mortality rate of 7,903 women (6.4 per 100,000 women). The proportion of cases of breast cancer detected during preventive examinations in 2022 was 34.9%. Globally, 662,301 new cases of cervical cancer and 348,874 deaths caused by the disease were reported in 2022. According to demographic development forecasts, by 2030, the incidence of breast cancer is expected to increase to 760,082 new cases (an increase of 14.8%), as well as an increase in the number of deaths to 411,035 (an increase of 17.8%). Russia is characterized by a higher incidence of breast cancer among women aged 29-34 years compared to other European countries, which is confirmed by data from the Global Cancer Observatory. Insufficient screening before the age of 30 using high-precision methods is a problem, since it is this age group that forms the majority of women capable of childbearing. Modern self-diagnostic methods based on biomaterial collection are highly sensitive and can significantly expand screening capabilities, which is necessary for the early detection and treatment of precancerous conditions.
self-sampling, HPV, test systems, kvant-21, prevalence, screening, Qvintip, Floqs, viral load
1. En'kova E.V. Dokazatel'naya medicina: indol-3-karbinol i resveratrol pri sostoyaniyah, associirovannyh s virusom papillomy cheloveka / En'kova E.V., Hoperskaya O.V., Shamarin S.V., En'kova V.V., Aseev A.V.; Medicinskiy sovet. 2024;18(17) - S. 74–81.
2. Shahzadova A.O. Sostoyanie onkologicheskoy pomoschi naseleniyu Rossii v 2022 godu / Shahzadova A.O., Starinskiy V.V., Lisichnikova I.V.; Sibirskiy onkologicheskiy zhurnal, 2023;22(5) - S. 5–13.
3. Kulieva G.Z. Epidemiologicheskie aspekty zabolevaemosti rakom sheyki matki i smertnosti ot nego (obzor literatury) / Kulieva G.Z., Mkrtchyan L.S., Krikunova L.I., Ivanov S.A., Kaprin A.D.; Opuholi zhenskoy reproduktivnoy sistemy, 2023; 19 (3) - S. 77-84. DOI: https://doi.org/10.17650/1994-4098-2023-19-3-77-84
4. En'kova E.V. Rasprostranennost' VPCh v populyacii zhenschin goroda Voronezha / En'kova E.V., Hoperskaya O.V., En'kova V.V., Karpova D.V. Voprosy prakticheskoy kol'poskopii. Genital'nye infekcii. 2022; (4) - S. 42–45.
5. Kesch'yan L.V. Vozmozhnost' VPCh-testirovaniya na primere obsledovaniya zhenschin Moskovskoy oblasti / Kesch'yan L.V., Zarochenceva N.V., Belaya Yu.M., Budykina T.S., Minina M.N., Ushakova S.V.; Rossiyskiy vestnik akushera-ginekologa. 2019;19(6) - S. 58‑64. DOI: https://doi.org/10.17116/rosakush20191906158
6. Fashedemi O. Advances in human papillomavirus detection for cervical cancer screening and diagnosis: challenges of conventional methods and opportunities for emergent tool / Fashedemi O., Ozoemena O. C., Peteni S., Haruna A. B., Shai L. J., Chen A., Rawson F., Cruickshank M. E., Grant D., Ola O., Ozoemena K. I.; Analytical methods: advancing methods and applications, 2025; 17(7) - S. 1428-1450.
7. Klinyshkova T.V. Strategii cervikal'nogo skrininga: sovremennyy vzglyad. Rossiyskiy vestnik akushera-ginekologa. 2023;23(4) - S. 20‑26. DOI: https://doi.org/10.17116/rosakush20232304120; EDN: https://elibrary.ru/FEHYEY
8. Wang S. Characteristics of human papillomavirus prevalence and infection patterns among women aged 25–64 according to age groups and cytology results in Ordos City / Wang S., Liu S., Tan S.; China. Virol. 2024;21(1) - 12 s. DOI: https://doi.org/10.1186/s12985-023-02240-7
